Literature DB >> 4599671

Comparison of ibuprofen and acetylsalicylic acid in the treatment of rheumatoid arthritis.

J Dornan, W J Reynolds.   

Abstract

A double-blind crossover study of ibuprofen and acetylsalicylic acid was carried out in 27 patients with rheumatoid arthritis. Patients were evaluated by joint counts, grip-strength determination, erythrocyte sedimentation rate, and number of acetaminophen tablets required in addition to the test drug, as well as by various biochemical measurements. In the doses used ibuprofen and acetylsalicylic acid appeared comparable in anti-inflammatory effect, but statistically fewer side effects were observed during administration of ibuprofen.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4599671      PMCID: PMC1947619     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Double-blind comparison of ibuprofen and phenylbutazone in the short-term treatment of rheumatoid arthritis.

Authors:  K Pavelka; A Susta; O Vojtísek; A Bremová; D Kanková; D Hándlová; J Malecek
Journal:  Rheumatol Rehabil       Date:  1973-05

3.  Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis.

Authors:  P L Boardman; G Nuki; F D Hart
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

4.  Clinical experience with Ibuprofen in the treatment of rheumatoid arthritis.

Authors:  T M Chalmers
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

5.  Further experience with ibuprofen in the treatment of arthritis.

Authors:  M Thompson; D Bell
Journal:  Rheumatol Phys Med       Date:  1970
  5 in total
  1 in total

1.  A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents.

Authors:  R E Pemberton; L J Strand
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.